Showing posts sorted by date for query SPAGYRIC. Sort by relevance Show all posts
Showing posts sorted by date for query SPAGYRIC. Sort by relevance Show all posts

Monday, August 10, 2026

SPAGYRIC HERBALISM

Natural insecticide made by nanoemulsification of compounds found in garlic and spearmint found to be effective on adzuki bean beetles with low non-target impacts



Researchers develop a new environmentally friendly insecticide against the adzuki bean beetle—a known legume pest—from nanoemulsions of diallyl disulfide and carvone



Kyushu University

Graphical abstract of the research 

image: 

Diallyl disulfide (DDS) is an organosulfur compound derived from garlic and (R)-carvone (Car) is a monoterpenoid derived from spearmint. These compounds were processed into oil-in-water nanoemulsions via ultrasonication. The nanoemulsions exhibited high toxicity and improved insecticidal efficacy against the adzuki bean beetle. Additionally, the nanoemulsions of both only DDS and its mixture with Car exhibited relatively low toxicity against the Anisopteromalus calandrae, a parasitic wasp that is the natural enemy of adzuki bean beetle.

view more 

Credit: Midori Tuda/Kyushu University





Fukuoka, Japan—In an effort to develop more environmentally friendly alternatives to synthetic insecticides, researchers from Kyushu University have developed and tested a new insecticide made from compounds derived from garlic and spearmint.

In their paper published in Ecotoxicology and Environmental Safety, the research team processed diallyl disulfide, an organosulfur compound derived from garlic, and R-carvone, a monoterpenoid from spearmint, into an emulsion of nanometer-sized droplets of oil-in-water. These nanoemulsions were then tested on a known legume pest called the adzuki bean beetle. They found that the insecticidal efficacy of the individual compounds was enhanced, and mixing the two compounds together added to their toxicity towards the pest.

“When people hear the term “insecticide,” they often think of synthetic chemicals that could be damaging to people and the environment. However, plants have evolved to produce compounds with potent insecticidal activity as a means of defending themselves from insect attack,” explains Urvashi Sahu, a JSPS postdoctoral fellow at Kyushu University’s Faculty of Agriculture and first author of the study. “In our research, we aim to develop ways to enhance the effect of natural insecticides.”

The team decided to utilize nanotechnology to develop a natural insecticide against the adzuki bean beetle Callosobruchus chinensis, a legume pest that causes significant postharvest losses. The compounds they turned to were diallyl disulfide (DDS) and R-carvone (Car), the active compounds found in garlic and spearmint, respectively. These are the compounds that give the plants their distinct odors.

Ultrasonication was used to emulsify both DDS and Car into oil-in-water droplets about 50-60 nm in diameter. These nanoemulsions were then placed in a container with adzuki bean beetles to test their insecticidal efficacy.

“We found that processing the compounds into nanoemulsions greatly enhanced their toxicity against the beetles. DDS showed a 30.5% increase in toxicity and Car toxicity increased by 8.2%,” continues Sahu.

Furthermore, the nanoemulsions had relatively low toxicity to Anisopteromalus calandrae, a known parasitic wasp that infects adzuki bean beetle larvae. Specifically, when half of the adzuki bean beetles die from the pesticide, only up to 22% of the wasps perished. This means that using both the nanoemulsions and parasitoid wasps can potentially enhance the effectiveness of pest control. The nanoemulsions were also safe on adzuki seeds and enhanced their root growth. No residual compounds were detected on the seeds themselves.

The next step for the team is to verify the efficacy of their new nanoemulsion under real-world environmental conditions and at large-scale grain and legume storage facilities. They also hope to elucidate the mechanism of how these nanoemulsions work to control the lifespan of the adzuki bean beetle.

“We will be looking into whether our insecticide can be effective on other pests. Our goal is to commercialize this technology as a sustainable, environmentally friendly alternative to pest control and management,” concludes Professor Midori Tuda, who led the research team. “Applying new technologies to compounds already found in nature holds massive potential for the future of science, agriculture, and humanity.”

###

For more information about this research, see "Enhanced toxicity of diallyl disulfide and carvone nanoemulsions against a stored bean pest and their nontarget effects on its parasitoid and seed viability," Urvashi Sahu, Eman Ahmed Mohamed Helmy, Midori Tuda, Ecotoxicology and Environmental Safety, https://doi.org/10.1016/j.ecoenv.2026.120374

About Kyushu University 
Founded in 1911, Kyushu University is one of Japan's leading research-oriented institutions of higher education, consistently ranking as one of the top ten Japanese universities in the Times Higher Education World University Rankings and the QS World Rankings. Located in Fukuoka, on the island of Kyushu—the most southwestern of Japan’s four main islands—Kyushu U sits in a coastal metropolis frequently ranked among the world’s most livable cities and historically known as Japan’s gateway to Asia. Its multiple campuses are home to around 19,000 students and 8,000 faculty and staff. Through its VISION 2030, Kyushu U will “drive social change with integrative knowledge.” By fusing the spectrum of knowledge, from the humanities and arts to engineering and medical sciences, Kyushu U will strengthen its research in the key areas of decarbonization, medicine and health, and environment and food, to tackle society’s most pressing issues.

Sunday, July 26, 2026

SPAGYRIC HERBALISM

Unlocking nature's pharmacy: Key regulator found for boosting active ingredients in traditional Chinese medicine




Nanjing Agricultural University The Academy of Science
A model for the role of PnMYB38 in MeJA-induced saponin biosynthesis. 

image: 

A model for the role of PnMYB38 in MeJA-induced saponin biosynthesis.

view more 

Credit: Horticulture Research





Sanchi ginseng (Panax notoginseng) is a cornerstone of traditional Chinese medicine, prized for its saponins—bioactive compounds with anti-inflammatory, cardiovascular, and anticancer properties. Yet the molecular machinery controlling saponin production has remained largely unknown. Now, researchers have identified a master regulator, the transcription factor PnMYB38, that acts as a molecular switch linking plant hormone signals to saponin biosynthesis. This discovery opens the door to precision breeding and metabolic engineering strategies that could boost the medicinal quality of this valuable herb.

For decades, scientists have known that methyl jasmonate (MeJA)—a plant hormone involved in stress responses—can significantly enhance saponin accumulation in P. notoginseng. However, the specific transcription factors (TFs) that translate this hormonal signal into increased saponin production remained unidentified. Transcription factors are proteins that bind to DNA and control which genes are turned on or off. Among them, the MYB family is one of the largest and most important in plants, regulating everything from growth to stress responses to the production of medicinal compounds. Due to these challenges, there is an urgent need for systematic research into how MeJA signaling is connected to saponin biosynthesis through MYB transcription factors.

A team of researchers from Kunming University of Science and Technology, in collaboration with the Wenshan Academy of Agricultural Sciences, published (DOI: 10.1093/hr/uhag052) their findings in Horticulture Research (Volume 13, Issue 6, 2026). The study combined genome-wide screening, multi-omics profiling, and molecular experiments to identify and characterize the MYB transcription factor family in P. notoginseng and pinpoint the key regulator responsible for MeJA-induced saponin production.

The research team identified 110 MYB genes in the P. notoginseng genome and found that MeJA treatment significantly altered the expression of 84 of them. By integrating transcriptomic and metabolomic data, they pinpointed PnMYB38 as a central hub in the regulatory network. Functional experiments confirmed that PnMYB38 directly binds to and activates the promoters of two critical saponin biosynthesis genes: PnSE (squalene epoxidase) and PnDS (dammarenediol-II synthase). This activation triggers a cascade that boosts the production of dammarane-type saponins, including notoginsenoside R₁—one of the most pharmacologically active compounds in Sanchi ginseng. The study also revealed that PnMYB38 is localized in the cell nucleus, consistent with its role as a transcriptional regulator. Through yeast one-hybrid (Y1H) assays, electrophoretic mobility shift assays (EMSA), and dual-luciferase (LUC) reporter assays, the researchers provided multiple lines of evidence confirming the direct and specific interaction between PnMYB38 and the target gene promoters.

"We've essentially found the missing link between the plant hormone signal and the production of these valuable medicinal compounds," the authors said. "PnMYB38 is the master switch that translates the methyl jasmonate cue into a blueprint for saponin biosynthesis. Understanding this mechanism not only solves a long-standing puzzle in plant biology but also gives us a precise molecular tool to improve the quality of Sanchi ginseng through breeding and genetic engineering."

This discovery has immediate and far-reaching implications for the cultivation and improvement of P. notoginseng. By targeting PnMYB38, breeders could develop varieties with consistently higher saponin content, reducing the variability that currently plagues commercial production. The findings also establish a clear regulatory model—the "MeJA–PnMYB38–saponin biosynthesis" pathway—that could guide metabolic engineering efforts in other medicinal plants. Furthermore, the study provides a foundation for using CRISPR/Cas9 gene-editing technology to precisely modulate saponin production. As demand for plant-based medicines continues to grow worldwide, this research offers a pathway to more sustainable, reliable, and high-quality production of one of traditional medicine's most treasured resources. The RNA-seq data generated in this study are publicly available through the China National GeneBank (CNGBdb) under project number PRJCA048040.

###

References

DOI

10.1093/hr/uhag052

Original Source URL

https://doi.org/10.1093/hr/uhag052

Funding information

Financial support from the Major Science and Technology Special Project of Yunnan Province (Grant No. 202202AG050021) and National Science Foundation of China (Grant No. 32360151). The Ability Establishment of Sustainable Use for Valuable Chinese Medicine Resources (Grant No. 2060302). Kunming University of Science and Technology Research Startup Fund (Grant No. KKZ3202560055).

About Horticulture Research

Horticulture Research is an open access journal of Nanjing Agricultural University and ranked number one in the Horticulture category of the Journal Citation Reports ™ from Clarivate, 2023. The journal is committed to publishing original research articles, reviews, perspectives, comments, correspondence articles and letters to the editor related to all major horticultural plants and disciplines, including biotechnology, breeding, cellular and molecular biology, evolution, genetics, inter-species interactions, physiology, and the origination and domestication of crops.

Saturday, July 18, 2026

SPAGYRIC HERBALISM

Saffron compound shows promise against fatty liver disease



Maximum Academic Press
Compound screenings identify Crocin II as a potential drug targeting ANGPTL8. 

image: 

Compound screenings identify Crocin II as a potential drug targeting ANGPTL8.

view more 

Credit: Compound screenings identify Crocin II as a potential drug targeting ANGPTL8.





A research team has identified Crocin II, a natural compound derived from saffron, as a promising therapeutic candidate for metabolic dysfunction-associated steatotic liver disease (MASLD). The study shows that Crocin II directly targets angiopoietin-like protein 8 (ANGPTL8), a liver-derived regulator of lipid metabolism and inflammation, and promotes its degradation through the autophagosome–lysosome pathway. By reducing ANGPTL8 protein levels, Crocin II alleviated liver fat accumulation, improved lipid profiles, reduced inflammatory changes, and enhanced glucose and insulin responses in experimental models.

MASLD has become one of the most common chronic liver diseases worldwide, affecting more than one-quarter of adults and closely linked to obesity, dyslipidemia, type 2 diabetes, cardiovascular disease, chronic kidney disease, and liver cancer. Although multiple therapeutic targets have been explored, including pathways involved in bile acid signaling and lipid metabolism, current drug development remains limited by insufficient efficacy, safety concerns, or translational barriers. ANGPTL8 has emerged as a valuable target because it participates in lipid regulation, inflammatory signaling, and hepatic metabolic rhythm. Existing ANGPTL8-targeted approaches, such as antisense oligonucleotides and monoclonal antibodies, have shown potential but face challenges including delivery limitations, high cost, instability, and possible side effects, highlighting the need for small-molecule or natural-compound alternatives.

A study (DOI: 10.48130/targetome-0026-0012) published in Targetome on 03 April 2026 by Chang Liu, Wenxiang Zhang & Siyu Chen's team, China Pharmaceutical University, reports that Crocin II binds ANGPTL8 and reduces MASLD progression by accelerating ANGPTL8 protein degradation.

To identify natural compounds capable of targeting ANGPTL8, the researchers built a saffron-derived small-molecule library containing 70 chemical monomers and performed molecular docking against human and mouse ANGPTL8. Crocin I and Crocin II showed strong predicted binding affinity, with Crocin II emerging as the more powerful candidate. The team then verified this interaction using several complementary assays. Cellular thermal shift assay and drug affinity responsive target stability analysis confirmed that Crocin II interacts with ANGPTL8 and promotes its degradation, while surface plasmon resonance showed that Crocin II had stronger binding affinity than Crocin I. Molecular dynamics simulations further indicated that the Crocin II–ANGPTL8 complex remained structurally stable over time. The researchers next examined how Crocin II reduced ANGPTL8 levels in mouse primary hepatocytes. Crocin II lowered both intracellular and secreted ANGPTL8 in a dose- and time-dependent manner without significant cellular toxicity. Protein stability tests showed that Crocin II shortened the half-life of ANGPTL8, while pathway inhibition experiments demonstrated that this degradation was mainly mediated by the autophagosome–lysosome system. Increased LC3B-II, decreased P62, transmission electron microscopy, and mCherry–eGFP–LC3 fluorescence imaging supported Crocin II-induced autophagic activation. Functional experiments showed that ANGPTL8 promoted lipid accumulation by increasing lipogenic genes such as Fasn, Dgat1, and Cidea and suppressing lipolytic genes such as Atgl. Crocin II reversed these effects and reduced free fatty acid-induced lipid accumulation in hepatocytes. In Angptl8-deficient cells, Crocin II produced little additional lipid-lowering effect, while Angptl8 overexpression weakened Crocin II's protective action, confirming that ANGPTL8 mediates the compound's metabolic benefit. In mice fed a high-fat diet, Crocin II reduced body weight gain, improved glucose tolerance and insulin sensitivity, lowered serum triglycerides, total cholesterol, low-density lipoprotein cholesterol, and the LDL-C/HDL-C ratio, and decreased liver injury markers. Histological staining showed less hepatic lipid deposition and macrophage infiltration, while liver triglyceride and cholesterol levels were markedly reduced. Untargeted lipidomics revealed that Crocin II reshaped hepatic lipid metabolism, reducing many triglyceride, diglyceride, cholesteryl ester, and fatty acyl species. Importantly, no overt toxic effects were observed in the kidney, heart, or spleen.

Together, the study reveals a natural-compound-based mechanism for targeting ANGPTL8 in MASLD. By promoting autophagic degradation of ANGPTL8, Crocin II reduced hepatic steatosis, improved systemic metabolic dysfunction, and showed favorable preliminary safety in animal experiments. The findings support Crocin II as a promising lead compound for future MASLD drug development and reinforce ANGPTL8 as an important therapeutic target for metabolic disease.

###

References

DOI

10.48130/targetome-0026-0012

Original Source URL

https://doi.org/10.48130/targetome-0026-0012

Funding information

This work was financially supported by grants from the National Key R&D Program of China (Grant No. 2022YFA0807200), the National Natural Science Foundation of China (Grant No. 32471201), the Natural Science Foundation of Jiangsu Province (Grant No. BK20220151), the Project of State Key Laboratory of Natural Medicines, China Pharmaceutical University (no. SKLNMZZ2024JS34), the Open Research Fund of Yunnan Characteristic Plant Extraction Laboratory (Grant No. YKKF2024018), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and The National Innovation and Entrepreneurship Training Program for Undergraduates.

About Targetome

Targetome refers to the complete collection of molecular targets (e.g., proteins, RNA or DNA) that interact with and mediate the effect of a specific biomolecule, such as a drug, toxin, metabolites, transcription factor or microRNA, within a biological system. Targetome is an open access journal publishing rigorously peer-reviewed original research articles, reviews, break-through methods, and perspectives that advance our understanding, identification and validation of molecular targets for new drug development.